logo
CAVA's First Ever Michigan Restaurant Opens in Canton

CAVA's First Ever Michigan Restaurant Opens in Canton

Business Wire8 hours ago
WASHINGTON--(BUSINESS WIRE)-- CAVA (NYSE: CAVA), the category-defining Mediterranean fast-casual restaurant brand, today opened its first location in Michigan, located at 43450 Ford Road, Canton, MI 48187. CAVA Canton is a 3,850-square-foot location with a dining room and digital order pick-up and delivery. Daily operating hours are 10:45 a.m. - 10 p.m. The brand has plans to expand its Michigan footprint later this year.
CAVA infuses every community it joins with the bold flavors and warm hospitality of the Mediterranean. Its fully customizable menu comprises of 38 ingredients, creating over 17 billion combinations for guests to enjoy through bowls, pitas, chips, dips, juices, and dressings. CAVA is expanding its mission to bring heart, health, and humanity to food throughout the country, with increasing momentum in the Midwest.
'We're thrilled to join the Southeast Michigan community and introduce more guests to the bold, vibrant flavors of the Mediterranean,' said Gino Carlin, Regional Leader at CAVA. 'Entering the state of Michigan marks our 28th state, and we're eager to welcome more guests in the Midwest and throughout the country to our table to enjoy our Mediterranean cuisine and hospitality.'
Before the doors officially open to any new restaurant, CAVA invites guests in for a complimentary meal, accepts donations to support a local cause, and matches those donations up to $1,000. Since 2019, this companywide Community Day program has raised more than $600,000 in donations, focused on organizations improving food insecurity in local communities. In keeping with this tradition, CAVA's Canton Community Day event was held yesterday, raising funds for Gleaners Food Bank of Southeast Michigan, a leading nonprofit organization dedicated to fighting hunger.
With a target of 1,000 restaurants by 2032, the company is quickly growing its national footprint, with plans to open additional restaurants in Michigan later this year. It opened 58 net new restaurants in the 2024 Fiscal Year and expects at least 17 percent growth in 2025. With its entrance into Michigan, CAVA's total national footprint reaches 28 states and the District of Columbia.
Prior to the grand opening, CAVA also donated fresh meals prepared throughout the restaurant's training period to local community members. The company's food donation program was launched nationally in the fall of 2023 to improve food insecurity and reduce food waste as CAVA expands to new locations.
CAVA's new Canton restaurant will employ 25-40 local people. The company hires people for their hospitality and warmth and is dedicated to creating career pathways for its team members. CAVA offers competitive pay and benefits including paid time off, healthcare, early wage access, an Employee Assistance Program, and free mental health support.
To learn more about CAVA, follow @CAVA on social channels, including TikTok, Instagram, LinkedIn, and Facebook.
About CAVA
CAVA is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. Our brand and our opportunity transcend the Mediterranean category to compete in the large and growing limited-service restaurant sector as well as the health and wellness food category. CAVA serves guests across gender lines, age groups, and income levels and benefits from generational tailwinds created by consumer demand for healthy living and a demographic shift towards greater ethnic diversity. We meet consumers' desires to engage with convenient, authentic, purpose-driven brands that view food as a source of self-expression. The broad appeal of our food combined with these favorable industry trends drive our vast opportunity for continued growth.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SM Energy (SM) Gets a Hold from Wells Fargo
SM Energy (SM) Gets a Hold from Wells Fargo

Business Insider

timean hour ago

  • Business Insider

SM Energy (SM) Gets a Hold from Wells Fargo

Wells Fargo analyst Hanwen Chang maintained a Hold rating on SM Energy on July 18 and set a price target of $30.00. The company's shares closed last Friday at $25.89. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Chang covers the Energy sector, focusing on stocks such as Vital Energy, Matador Resources, and SM Energy. According to TipRanks, Chang has an average return of -2.8% and a 38.24% success rate on recommended stocks. In addition to Wells Fargo, SM Energy also received a Hold from J.P. Morgan's Zach Parham in a report issued on July 10. However, on July 16, Siebert Williams Shank & Co maintained a Buy rating on SM Energy (NYSE: SM). Based on SM Energy's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $844.54 million and a net profit of $182.27 million. In comparison, last year the company earned a revenue of $559.87 million and had a net profit of $131.2 million Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock. Last month, Richard A. Jenkins, the SVP – Utah of SM sold 7,726.00 shares for a total of $220,113.74.

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

Yahoo

timean hour ago

  • Yahoo

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) and set a price target of $250.00. A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) reported positive fiscal Q1 2025 results that support the optimistic outlook, with adjusted diluted EPS reaching $2.46, experiencing a 6.5% growth. The company also reported $13.343 billion in net revenue for the first quarter of 2025, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi

Yahoo

timean hour ago

  • Yahoo

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to strategically expand its partnership with Sanofi to support additional drug product manufacturing in the United States. A workstation in a research lab stocked with laboratory products and services. As part of the partnership, Thermo Fisher Scientific Inc. (NYSE:TMO) would acquire Sanofi's manufacturing site in Ridgefield, New Jersey, and would continue to produce and develop a portfolio of therapies for Sanofi. Thermo Fisher Scientific Inc. (NYSE:TMO) also plans to expand use of the site to satisfy the rising demand from biotech and pharma customers for US manufacturing capacity. The Ridgefield site will join Thermo Fisher Scientific Inc. (NYSE:TMO) after the completion of the transaction, and comprises a state-of-the-art sterile fill-finish and packaging facility with over 200 employees. Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store